WHO Pharmaceuticals Newsletter 1998, No. 11&12
(1998; 10 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Open this folder and view contentsDrug surveillance
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Close this folderGeneral information
View the documentAllergen extract or allergen patch test: draft guidance available: USA
View the documentAntimicrobial drug products: draft guidances available: USA
View the documentDrugs for Dementia: guide available: UK
View the documentNon-contraceptive estrogens labelling: draft guidance available: USA
View the documentOut of specification test results: draft guidance available: USA
View the documentVaginal yeast infections (vulvovaginal candidiasis): draft guidance available on labelling of OTC products: USA
Open this folder and view contentsMedication errors
Open this folder and view contentsVeterinary medicine
 

Allergen extract or allergen patch test: draft guidance available: USA

United States of America. The Food and Drug Administration has announced the availability of a draft guidance document entitled “Guidance for Industry: On the Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for an Allergen Extract or Allergen Patch Test”, which provides guidance for marketing applications.

Copies of the draft guidance are available from the Office of Communication, Training and Manufacturers Assistance (HFM-40), Center for Biologics Evaluation and Research (CBER), 1401 Rockville Pike, Rockville MD 20852-1448, USA (with one self-addressed adhesive label) or from the Internet at: http://www.fda.gov/cber/guidelines.htm.

Reference: Federal Register 63(166): 45826-7 (1998).

to previous section to next section
 

Last updated: May 3, 2013